by Selma Stern, Simon Chorzelski, Laura Franken et al.
The Boston Consulting Group (BCG) for the German Federal Ministry of Health, February 2017
In the face of the lack of attractiveness of investing in research for new antibiotics for the pharmaceutical industry, and the general lack of funding for research and development for novel antibiotics, this new report commissioned by the German Federal Ministry of Health calls for countries to take action. In particular, the report proposes a global union for research and development, a global research fund, and a global launch reward. And access and pricing are key components of the strategy, it says.